ICU Medical, Inc. / Fundamentals
Income statement
- Net revenue
€2.04B - Cost of goods sold
€1.31B - Gross profit
€729.54M - SG&A expenses
€547.56M - R&D expenses
€75.97M - EBITDA
€233.10M - D&A
€135.79M - EBIT
€59.55M - Interest expenses
€46.77M - EBT
€11.21M - Tax expenses
€37.50M - Net income
-€31.70M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€6.75M - Changes in working capital
-€68.85M - Operating cash flow
€119.11M - Capex
€66.73M - Other investing cash flow
€167.05M - Net investing cash flow
€104.03M - Total cash dividends paid
€0.00 - Issuance of common stock
€2.37M - Debt repayment
-€192.27M - Other financing cash flow
-€3.09M - Net financing cash flow
-€231.59M - Foreign exchange effects
€6.20M - Net change in cash
-€2.25M - Cash at end of period
€257.42M - Free cash flow
€185.84M
Balance sheet
- Cash and cash equivalents
€257.42M - Cash and short-term investments
€257.42M - Total receivables
€188.05M - Inventory
€528.94M - Other current assets
€38.13M - Total current assets
€1.01B - Property, plant & equipment
€438.72M - Goodwill
€1.29B - Intangible assets
€598.89M - Long-term investments
€112.93M - Other non-current assets
€52.61M - Total non-current assets
€2.51B - Total assets
€3.52B - Accounts payable
€144.85M - Short-term debt
€12.64M - Other current liabilities
€237.79M - Total current liabilities
€414.22M - Long-term debt
€1.19B - Deferred tax liabilities
€37.08M - Other non-current liabilities
€64.69M - Total non-current liabilities
€1.29B - Total liabilities
€1.71B - Common stock
€2.12M - Retained earnings
€609.20M - Other equity
-€28.01M - Total equity
€1.82B - Total liabilities and shareholders' equity
€3.52B
Company information
- Market capitalization
€2.77B - Employees
15K - Enterprise Value
€4.56B
Company ratios
- Gross margin
-
35.8% Worse than peer group: 49.7% - EBITDA margin
-
11.5% Even with peer group: 12.7% - EBIT margin
-
2.9% Even with peer group: 6.8% - EBT margin
-
0.6% Much better than peer group: -119.1% - Net margin
-
-1.6% Even with peer group: 2.7% - ROE
-
-1.7% Even with peer group: -2.8% - ROA
-
-0.9% Even with peer group: 2.9% - Asset turnover
-
57.8% Worse than peer group: 76.8% - FCF margin
-
2.6% Even with peer group: 3.6% - FCF yield
1.9% - Efficiency ratio
88.5% - Net sales per employee
-
€135.71K - Net income per employee
-
-€2.11K